EurekAlert!

Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A

Cyclooxygenase-2 is overexpressed in bladder cancer cells, making it an attractive molecular target for the detection and treatment of cancer. Cyclooxygenase-2 is overexpressed in bladder cancer cells ...
MedPage Today

First-Line Bladder Cancer Trial Makes the Case for HER2 Screening

BERLIN -- A Chinese trial that screened advanced urothelial cancer patients for HER2-expression demonstrated a large survival benefit with a novel chemotherapy-free combination in the first-line ...
ascopubs.org

Targeting epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 expressing bladder cancer using combination photoimmunotherapy (PIT).

Concurrent chemoradiotherapy (CRT) for bladder cancer: Practice patterns and outcomes in the general population. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract ...
Labroots

Using Transcription Factors to Predict Bladder Cancer Prognosis

Bladder cancer is a rare form of cancer, with a relatively high recovery rate. Recurrence is still an issue; however, with around half of patients affected. Prognostic tests can help identify patients ...
FierceBiotech

Celldex Therapeutics Announces Initiation of Randomized Phase 2 Clinical Trial of CDX-1307 in Front Line Bladder Cancer

NEEDHAM, Mass.--(BUSINESS WIRE)-- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been screened in a randomized Phase 2 study of the Company’s novel, ...
Yahoo Finance

Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End

Long-term survivors in both oral PV-10 arms showed an absence of gross bladder tumor at necropsy, a finding not observed in any untreated, vehicle-control, or anti-PD-1 monotherapy animal. Across the ...